Affordable Access

Frentizole therapy in systemic lupus erythematosus.

Authors
  • Sabharwal, U K
  • Vaughan, J H
  • Kaplan, R A
  • Robinson, C A
  • Curd, J G
Type
Published Article
Journal
Arthritis and rheumatism
Publication Date
Dec 01, 1980
Volume
23
Issue
12
Pages
1376–1380
Identifiers
PMID: 7006612
Source
Medline
License
Unknown

Abstract

Seven corticosteroid dependent patients with active systemic lupus erythematosus (SLE) were given frentizole in order to assess its effect on their clinical manifestations. Three patients exhibited slight clinical improvement, 2 patients did not change, and 2 deteriorated. Five of the 7 patients developed subclinical and reversible liver damage related to frentizole. This study, although preliminary and uncontrolled, suggests that frentizole is of limited value in the management of patients with SLE.

Report this publication

Statistics

Seen <100 times